NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

1 min read

AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings

August 5, 2021 at 9:00 AM
Press Release
Read press release

1 min read

AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site

August 2, 2021 at 11:00 AM
Press Release
Read press release

2 min read

AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings

July 1, 2021 at 9:00 AM
Press Release
Read press release

4 min read

Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III

June 23, 2021 at 5:30 AM
Press Release
Read press release

1 min read

AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine

June 7, 2021 at 7:00 AM
Press Release
Read press release

2 min read

AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics

May 19, 2021 at 10:06 AM
Press Release
Read press release

2 min read

Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02

May 6, 2021 at 7:00 AM
Events and Conferences
Read press release

1 min read

Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility

April 30, 2021 at 7:00 AM
Read press release

1 min read

AGC Biologics Expands Partnership with Rocket Pharmaceuticals

April 20, 2021 at 6:53 AM
Press Release
Read press release

1 min read

AGC Biologics Appoints Jun Takami to General Manager/Site Head of Their Chiba, Japan Site

April 8, 2021 at 7:00 AM
Press Release
Read press release
Prev 7 8 9 10 11 Next